GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanco Animal Health Inc (STU:5EA) » Definitions » ROC (Joel Greenblatt) %

Elanco Animal Health (STU:5EA) ROC (Joel Greenblatt) % : 83.34% (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Elanco Animal Health ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Elanco Animal Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 83.34%.

The historical rank and industry rank for Elanco Animal Health's ROC (Joel Greenblatt) % or its related term are showing as below:

STU:5EA' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -35.83   Med: -6.74   Max: 22.82
Current: 22.82

During the past 9 years, Elanco Animal Health's highest ROC (Joel Greenblatt) % was 22.82%. The lowest was -35.83%. And the median was -6.74%.

STU:5EA's ROC (Joel Greenblatt) % is ranked better than
70.91% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 9.36 vs STU:5EA: 22.82

Elanco Animal Health's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Elanco Animal Health ROC (Joel Greenblatt) % Historical Data

The historical data trend for Elanco Animal Health's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elanco Animal Health ROC (Joel Greenblatt) % Chart

Elanco Animal Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only 7.78 -21.78 -14.97 7.64 -35.34

Elanco Animal Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -148.61 -8.72 10.28 3.97 83.34

Competitive Comparison of Elanco Animal Health's ROC (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, Elanco Animal Health's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elanco Animal Health's ROC (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanco Animal Health's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Elanco Animal Health's ROC (Joel Greenblatt) % falls into.



Elanco Animal Health ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(928.071 + 1496.619 + 839.816) - (270.339 + 330.724 + 473.79)
=2189.653

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(756.84 + 1470.432 + 306.34) - (233.359 + 300.033 + 617.185)
=1383.035

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Elanco Animal Health for the quarter that ended in Sep. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2223.668/( ( (881.621 + max(2189.653, 0)) + (882.079 + max(1383.035, 0)) )/ 2 )
=2223.668/( ( 3071.274 + 2265.114 )/ 2 )
=2223.668/2668.194
=83.34 %

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elanco Animal Health  (STU:5EA) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Elanco Animal Health ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Elanco Animal Health's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Elanco Animal Health Business Description

Traded in Other Exchanges
Address
2500 Innovation Way, Greenfield, IN, USA, 46140
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Elanco Animal Health Headlines

No Headlines